Buch, Englisch, 531 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 978 g
ISBN: 978-981-97-4969-0
Verlag: Springer Nature Singapore
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Biotechnologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin
Weitere Infos & Material
Chapter 1_Fundamentals of targeted drug delivery.- Chapter 2_Influence of drug properties and routes of drug administration on design of sustained and controlled release systems.- Chapter 3_Polymeric materials in controlled drug delivery.- Chapter 4_Biopharmaceutic and pharmacokinetic aspects of peroral Controlled Drug Delivery Systems.- Chapter 5_Parenteral drug delivery.- Chapter 6_Proteins / peptides drug delivery systems.- Chapter 7_Transdermal / skin drug delivery system.- Chapter 8_Implantable Therapeutics Systems.- Chapter 9_Chemical drug delivery systems.- Chapter 10_Targeted brain delivery.- Chapter 11_Targeted Tumor Delivery.- Chapter 12_Miscellaneous targeting approaches: Fundamentals of gene delivery, Overview of colon, liver, macrophage, mitochondrial and M cells targeting.- Chapter 13_Overview of Specialized drug delivery systems: Transfersomes, Ethosomes, Layersomes, Bilosomes,Emulsomes, Virosomes, Cubosomes, Aquasomes, Pharmacosomes. Dendrimers, Polymeric Micelles and Resealed Erythrocytes.- Chapter 14_Controlled release formulations for alternate routes of administration.- Chapter 15_Stimuli responsive drug delivery systems: Magnetically, thermal and pH-assisted drug delivery systems.- Chapter 16_Role of controlled release in veterinary formulations.- Chapter 17_Colloidal drug delivery systems: (a) Liposomes and niosomes.- Chapter 18_Solid lipid nanoparticles and nanostructured lipid carriers.- Chapter 19_Polymeric nanoparticles – PLGA, chitosan, albumin, gelatin, alginate etc and Carbon nanotubes.- Chapter 20_Theranostics Application of Controlled Release Drug Delivery systems.- Chapter 21_Regulatory approval pathways involved in controlled release formulations.